1-173825318-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_018122.5(DARS2):c.89A>G(p.Tyr30Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018122.5 missense
Scores
Clinical Significance
Conservation
Publications
- leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndromeInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DARS2 | NM_018122.5 | c.89A>G | p.Tyr30Cys | missense_variant | Exon 1 of 17 | ENST00000649689.2 | NP_060592.2 | |
DARS2 | NM_001365212.1 | c.89A>G | p.Tyr30Cys | missense_variant | Exon 1 of 16 | NP_001352141.1 | ||
DARS2 | NM_001365213.2 | c.89A>G | p.Tyr30Cys | missense_variant | Exon 1 of 14 | NP_001352142.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251468 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461618Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 727116 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74304 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.89A>G (p.Y30C) alteration is located in exon 1 (coding exon 1) of the DARS2 gene. This alteration results from a A to G substitution at nucleotide position 89, causing the tyrosine (Y) at amino acid position 30 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 30 of the DARS2 protein (p.Tyr30Cys). This variant is present in population databases (rs758005860, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1915175). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt DARS2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at